LESLEY NEVENZEL: Open Payments
NPI 1093023228 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 13 payments from 6 companies in 2025. Trend: 2023 $252 · 2024 $627 · 2025 $313
Food & beverage: $300Education: $14
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Madrigal Pharmaceuticals | 2 | $57 |
| ABBVIE INC. | 2 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, RINVOQ, LINZESS, XIFAXAN, ZENPEP, EOHILIA.
Industry payments across MI — which companies pay providers there.
